Star Pharma - Company & Market Research Reports

Starpharma is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications. Starpharma’s underlying technology is built around dendrimers – a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses. Starpharma has three core development programs: VivaGel® portfolio, DEP™ drug delivery, and agrochemicals with the company developing a number of products internally and others via commercial partnerships. They are headquartered in Melbourne Australia.


Nanoparticle Drug Delivery Market Report - Product Thumbnail Image

Nanoparticle Drug Delivery Market Report

  • Report
  • 301 Pages
Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 132 Pages
From
Genital Herpes - Pipeline Review, H1 2018 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H1 2018

  • Report
  • 88 Pages
From
Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016 - Product Thumbnail Image

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

  • Report
  • 177 Pages
From
Herpes Simplex Infections - Pipeline Review, H2 2015 - Product Thumbnail Image

Herpes Simplex Infections - Pipeline Review, H2 2015

  • Report
  • 185 Pages
From
Human Papillomavirus Infections - Pipeline Review, H2 2015 - Product Thumbnail Image

Human Papillomavirus Infections - Pipeline Review, H2 2015

  • Report
  • 164 Pages
From
Herpes Simplex Virus Treatment - Global Strategic Business Report - Product Thumbnail Image

Herpes Simplex Virus Treatment - Global Strategic Business Report

  • Report
  • 300 Pages
From
Herpes Simplex Infections - Pipeline Review, H1 2015 - Product Thumbnail Image

Herpes Simplex Infections - Pipeline Review, H1 2015

  • Report
  • 188 Pages
From
Human Papillomavirus Infections - Pipeline Review, H1 2015 - Product Thumbnail Image

Human Papillomavirus Infections - Pipeline Review, H1 2015

  • Report
  • 144 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017

  • Report
  • 980 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017

  • Report
  • 919 Pages
From
HIV / AIDS - Pipeline Review, H1 2016 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2016

  • Report
  • 886 Pages
From
HIV / AIDS - Pipeline Review, H2 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H2 2015

  • Report
  • 916 Pages
From
HIV / AIDS - Pipeline Review, H1 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2015

  • Report
  • 871 Pages
From
Nanotechnology in Medical Applications: The Global Market - Product Thumbnail Image

Nanotechnology in Medical Applications: The Global Market

  • Report
  • 121 Pages
From
Nanomedicine - Global Strategic Business Report - Product Thumbnail Image

Nanomedicine - Global Strategic Business Report

  • Report
  • 698 Pages
From
Ovarian Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H2 2017

  • Report
  • 2232 Pages
From
Ovarian Cancer - Pipeline Review, H1 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2017

  • Report
  • 2027 Pages
From
Metastatic Breast Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H2 2016

  • Report
  • 1096 Pages
From
Breast Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Breast Cancer - Pipeline Review, H1 2016

  • Report
  • 3011 Pages
From
Loading Indicator
adroll